Edition:
India

Invion Ltd (IVX.AX)

IVX.AX on Australia Stock Exchange

0.01AUD
4 Dec 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
206,599
Avg. Vol
1,441,774
52-wk High
$0.02
52-wk Low
$0.01

Summary

Name Age Since Current Position

Thian Chew

2017 Non-Executive Chairman of the Board

Craig Newton

2019 Chief Executive Officer

Melanie Leydin

2020 Chief Financial Officer

Alistair Bennallack

2020 Non-Executive Director

Gregory Collier

2019 Non-Executive Director

Melanie Farris

2019 Non-Executive Director

Rob Merriel

2020 Non-Executive Director

Alan Yamashita

2019 Non-Executive Director

Biographies

Name Description

Thian Chew

Mr. Thian C. Chew is Non-Executive Chairman of the Board of the Company. Mr Chew was previously an Executive Director at Goldman Sachs (Hong Kong and New York) responsible for the firm’s proprietary investments including growth capital, private equity and special situations in both private and public companies. Prior to this, he was a Consultant Project Manager to Morgan Stanley, New York. Mr Chew also held a number of positions in KPMG across Asia Pacific including Director at KPMG Consulting (Singapore and Sydney) where he led several large scale operational restructuring, post-merger transformation, and business performance improvement programs. As a Senior Manager at KPMG (Taipei and Melbourne), he led several business process re-engineering initiatives, and also performed financial and information technology audit, risk and assurance engagements across multiple industries. Mr Chew holds an MBA from the Wharton School (Palmer Scholar), MA from the Lauder Institute, University of Pennsylvania, and a Bachelor of Information Systems from Monash University. Mr Chew is an Adjunct Professor at HKUST’s MBA program and previously qualified as a chartered accountant.

Craig Newton

Mr. Craig Newton is appointed as Chief Executive Officer of the Company, effective November 1. 2019. Craig Newton joined Invion as Chief Operating Officer in April 2018. Since that time, Craig has recruited a strong and experienced clinical development team. Craig has over 30 years of experience in senior business and operational roles gained at various leading global companies including CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals.

Melanie Leydin

Ms. Melanie Leydin serves as Chief Financial Officer of the Company. Ms Leydin is a member of the Institute of Chartered Accountants, Fellow of the Governance Institute of Australia and is a Registered Company Auditor. She brings extensive experience in public company responsibilities to Invion that spans over 25 years and has an established track record in areas such as statutory financial reporting, financial forecasting and budgets, internal controls, ASX and ASIC compliance, corporate governance and shareholder relations. Since February 2000, Ms Leydin has been the principal of chartered accounting firm, Leydin Freyer. The practice provides outsourced accounting and company secretarial services to public and private companies across a host of industries, including but not limited to the bioscience, biotechnology, health sectors and technology. Ms Leydin graduated from Swinburne University with a Bachelor of Business majoring in Accounting and Corporate Law and became in Chartered Accountant in 1999.

Alistair Bennallack

Mr. Alistair Bennallack serves as Non-Executive Director of the Company. Mr Bennallack has over 30 years’ experience in business management and finance, strategic development, risk and compliance, international business, leadership and relationship management. Mr Bennallack is currently the Chief Executive Officer of Village Roadshow Theme Parks Asia and Head of Risk at Village Roadshow Ltd with the primary executive responsibility for conceptualising, executing and delivering Village Roadshow’s expansion into China and Asia. He is a former member of the Village Roadshow Ltd Executive Committee, current member of the Village Roadshow Theme Parks Executive Committee and current member of all Village Roadshow Ltd’s Management and Risk Committees. His previous roles have included Chief Financial Officer of Village Roadshow Ltd and General Manager Business Affairs of Village Roadshow Corporation Pty Ltd (controlling shareholder of Village Roadshow Ltd). Mr Bennallack is a member of the Institute of Chartered Accountants in Australia and has a Graduate Diploma in Wine Business. He is also the former President and Board Member of The Gawler Foundation.

Gregory Collier

Dr. Gregory R. Collier, Ph.D. is re-designated as Non-Executive Director of the Company, effective 31 October 2019. He is no longer Chief Executive Officer, Managing Director, Executive Director of the Company, effective 31 October 2019. He has more than 20 years experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialization. He has led the planning and execution of multiple commercial transactions including in and out licensing deals and M&A activities, and he has taken a drug from discovery through to regulatory approval. Prior to his commercial pharmaceutical career, Dr. Collier had an academic career resulting in over 150 peer reviewed publications, and senior authorship on 33 patents. Dr Collier was the inaugural Alfred Deakin Professor at Deakin University, and also held positions at Melbourne University, Monash University and the University of Toronto. In 2010, Dr. Collier was awarded the Roche Award of Excellence for his contribution to the biotechnology industry.

Melanie Farris

Ms. Melanie Farris serves as Non-Executive Director of the Company. Ms. Farris is a Certificated Member of Chartered Secretaries Australia. She joined CBio in 2007, and prior to being appointed Company Secretary in 2012 held responsibility for investor relations and corporate affairs. Melanie has a background in marketing communications across biotechnology, investment, media and not-for-profit groups. An experienced secretary in the not-for-profit sector, Ms Farris is a Certificated Member of Chartered Secretaries Australia.

Rob Merriel

Mr. Rob Merriel serves as Non-Executive Director of the Company. Mr Merriel brings deep healthcare sector experience and strong commercial expertise to the Board of Invion. He is a Certified Practicing Accountant (CPA) with over 35 years of experience working in medical research (Hudson Institute of Medical Research and Baker Institute), large public healthcare services (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). He is currently on the Boards of two biotechnology start-up companies, he has been a Director of two Venture Capital Funds and a Director and Company Secretary of several biotechnology focused medical research institute spin-off companies.

Alan Yamashita

Mr. Alan Yamashita is Non-Executive Director of the Company. Mr. Yamashita has more than 40 years’ experience in investment management, investment banking and alternative investment. Formerly Managing Director and Head of Asia Capital Markets at Merrill Lynch as well as a 16-year veteran of Goldman Sachs, Mr Yamashita is currently Managing Partner at Polar Ventures, a private investment firm that provides capital, strategic and operating solutions, focusing on small- to medium-sized enterprises in Asia.

Basic Compensation